Projects per year
Personal profile
Research
Our research focuses on personalized medicine for renal cancer patient management. We aim to identify markers that can improve the treatment and thus survival for RCC patients. We will accomplish this through a comprehensive analysis of the tumor, tumor environment, blood, and fecal samples.
Areas of expertise
- Kidney Cancer
- Translationel Research
- Liquid Biopsy
- Biomarker Development
Fingerprint
Dive into the research topics where Iben Lyskjær Heimann is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
-
Harnessing the molecular landscape to improve renal cancer patient management
01/02/2023 → 01/07/2028
Project: Research
-
Development of a device for electroporation from the tip of an endoscope: A novel, minimal invasive surgical procedure
Ørntoft, M.-B. W. (Participant), Heimann, I. L. (Participant), Callesen, M. M. (Participant), Rasmussen, M. H. (Participant), Uhre, V. (Participant) & Geert, T. (Participant)
01/10/2015 → 01/01/2018
Project: Research
-
Inducible Colorectal Cancer in a Porcine Model
Callesen, M. M. (Participant), Heimann, I. L. (Participant), Ørntoft, M.-B. W. (Participant) & Andersen, C. L. (Participant)
01/10/2014 → 30/11/2016
Project: Research
-
Circulating tumour DNA and risk of recurrence in patients with asymptomatic versus symptomatic colorectal cancer
Øgaard, N., Jensen, S. Ø., Ørntoft, M.-B. W., Demuth, C., Rasmussen, M. H., Henriksen, T. V., Nors, J., Frydendahl, A., Lyskjær, I., Nesic, M., Therkildsen, C., Kleif, J., Gögenur, M., Jørgensen, L. N., Vilandt, J., Seidelin, J. B., Gotschalck, K. A., Jaensch, C., Andersen, B. & Løve, U. S. & 12 others, , Nov 2024, In: British Journal of Cancer. 131, 10, p. 1707-1715 9 p.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Open Access -
Editorial: Epigenetic biomarkers for cancer risk stratification and patient management
Tanić, M., Ecker, S. & Lyskjær, I., May 2024, In: Frontiers in Genetics. 15, 2 p., 1421500.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Editorial
Open Access -
Epigenetic age acceleration is a distinctive trait of epithelioid sarcoma with potential therapeutic implications
Haefliger, S., Chervova, O., Davies, C., Loh, C., Tirabosco, R., Amary, F., Pillay, N., Horvath, S., Beck, S., Flanagan, A. M. & Lyskjær, I., Oct 2024, In: GeroScience. 46, 5, p. 5203-5209 7 p.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Letter › peer-review
-
KIDNEY-PAGER: analysis of circulating tumor DNA as a biomarker in renal cancer - an observational trial. Study protocol
Iisager, L., Ahrenfeldt, J., Keller, A. K., Nielsen, T. K., Fristrup, N. & Lyskjær, I., 23 Feb 2024, In: Acta oncologica (Stockholm, Sweden). 63, p. 51-55 5 p.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Open Access1 Citation (Scopus) -
Management of renal cell carcinoma: promising biomarkers and the challenges to reach the clinic
Lyskjær, I., Iisager, L., Axelsen, C. T., Nielsen, T. K., Dyrskjøt, L. & Fristrup, N., Feb 2024, In: Clinical Cancer Research. 30, 4, p. 663-672 10 p.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Review › Research › peer-review
Open Access6 Citations (Scopus)